Justin Z. Wang
@justinzw
Followers
851
Following
5K
Media
113
Statuses
1K
@UofTNeuroSurge Chief Resident | MD, PhD | Skull Base Oncology Fellow @TJUHNeurosurg ‘26-‘27
Toronto, Ontario
Joined June 2013
Read the new #ICOM collaboration paper in @NeuroOnc which provides a data-driven approach for integrating prediction models for personalized #meningioma care: https://t.co/J7yQPv9Eav
@ap_landry @gelarehzadeh @FarshadNassiri
0
7
16
The https://t.co/BZkJQwzQg7 is my greatest career joy -amazing people who build the frame for those who travel through for their studies Working across great #institutions @MayoClinicNeuro @MayoClinic @UofTNeuroSurge @UofTSurgery #WFNOS2025
1
8
76
Another productive @ICOMeningioma meeting @NeuroOnc with great talks and fruitful discussions. Thanks to all who joined! Welcoming new members icom@meningiomaconsortium.com @gelarehzadeh @FarshadNassiri
0
4
16
Great news! Dr Nir Lipsman has been appointed as the Dan Family Professor and Chair of Neurosurgery @UofTNews @UofTNeuroSurge @UofTSurgery @uoftmedicine effective January 1 2026! Our future is indeed bright!
2
2
43
New #zadehlab paper out in @NeuroOnc providing a data-driven approach for integrating prediction models for personalized meningioma care. Special thanks to mentors @gelarehzadeh @FarshadNassiri, helpful reviewers, and many collaborators @ICOMeningioma
https://t.co/9xcrKgZVbA
academic.oup.com
AbstractBackground. DNA methylation profiling can be used to robustly predict postsurgical outcomes and response to radiotherapy (RT) for meningioma patien
1
8
27
Can DNA methylation risk groups unlock personalized radiotherapy decisions in meningioma? Our new paper provides the clinical framework — thanks to all collaborators! https://t.co/4BKUuhvPYq
@ICOMeningioma @NeuroOnc @ASTRO_org @ESTRO_RT @gelarehzadeh @FarshadNassiri @ap_landry
academic.oup.com
AbstractBackground. DNA methylation profiling can be used to robustly predict postsurgical outcomes and response to radiotherapy (RT) for meningioma patien
0
4
13
Excited to share our new study in @NeuroOnc in which we show that a molecular tool built in a predominantly adult meningioma cohort does not generalize well to adolescent and young adult (AYA) patients. https://t.co/0ZlP6we8ZS
academic.oup.com
AbstractBackground. Adolescent and young adult (AYA) patients remain underrepresented in neuro-oncology research. Despite being the second most common prim
1
6
9
End of rotation for @PranjanGandhi who has been with me through thick and thin for over 1/3 of my chief residency through @UHN and @Sunnybrook- a gifted clinician and future star in cerebrovascular surgery- one to keep an eye out for! He will be missed!! @UofTNeuroSurge
2
6
38
rising #stars @zadehlab presentations & awards @CNS_Update #CNS2025 @chloegui_ @AndrewAjisebutu @lsyefet @YosefEllenbogen @UofTNeuroSurge @uoftmedicine @MayoClinicNeuro @MayoClinic
0
1
45
A new article in @BrainTumourOrg highlights the findings from the Lancet Oncology paper ‘Analysis of TERT association with clinical outcome in #meningiomas: a multi-institutional cohort study’ https://t.co/0DKa93EoDY
0
7
32
Our work led by @chloegui_ outstanding #neurosurgery #phd student #TERT expression #predictor of aggressive behaviour Together with the field we are better understanding #meningiomas
@justinzw @ap_landry @FarshadNassiri @wenyalindabi @ICOMeningioma Grateful to @BrainTumourOrg
Meningiomas are usually low-grade, but they sometimes behave more aggressively than doctors expect. The Charity is funding a growing body of research led by Dr Gelareh Zadeh to improve understanding of these tumours. #BrainTumours #LowGrade #Meningioma
2
7
49
Meningiomas are usually low-grade, but they sometimes behave more aggressively than doctors expect. The Charity is funding a growing body of research led by Dr Gelareh Zadeh to improve understanding of these tumours. #BrainTumours #LowGrade #Meningioma
1
4
23
Last official day of my chief rotation @UHN TWH vs my 1st day of residency here! A few more greys, more than a few new wrinkles, and a lot of new faces. Privileged to work with gifted residents, supportive allied health, and generous staff @UofTNeuroSurge @UofTSurgery
6
6
86
Congrats @LaureenHachem 🙌🙌🙌
IMS researchers @LaureenHachem, @DrFehlings and @CharlesTator have discovered a promising new way the body could heal itself after spinal cord injury by harnessing the power of hidden stem cells. https://t.co/CTVjdWCcSI
0
0
9
Our new special edition on brain tumor immunotherapy is out today in @EditorNeuro, led by world-experts @GavinPDunn @MichaelLimMD. Thanks to authors, peer-reviewers, and editors for the invaluable contributions @gelarehzadeh @FarshadNassiri @OUPAcademic
https://t.co/tqxQRoJIJ4
3
14
55
📢Sept podcast: Kat Gourd, Acting Deputy Editor, is joined by @wenyalindabi, @RuchitVP, @chloegui_, @FarshadNassiri, Matija Snuderl to discuss two exciting papers on TERT expression and TERT promoter mutations in #meningiomas
https://t.co/zwluRcwf05
0
1
4
Lots of fun chatting with Kat Gourd @TheLancetOncol about findings of joint papers on TERT in meningioma @gelarehzadeh @chloegui_ @ICOMeningioma submitted together with @wenyalindabi #MSnuderl and team. Remembering K Groff Looking forward to working on next steps together!
📢Sept podcast: Kat Gourd, Acting Deputy Editor, is joined by @wenyalindabi, @RuchitVP, @chloegui_, @FarshadNassiri, Matija Snuderl to discuss two exciting papers on TERT expression and TERT promoter mutations in #meningiomas
https://t.co/zwluRcwf05
2
4
26
#ICOM and some of our members just published an article in @TheLancetOncol investigating the prevalence and prognostic association of #TERT expression in #meningiomas, with implications for diagnosis & treatment: https://t.co/S3e3y7MB14
@gelarehzadeh @FarshadNassiri @ap_landry
0
2
14
🚨New #pub @TheLancetOncol from our team @ICOMeningioma , led by ⭐️@chloegui_ ⭐️ In >1,200 #meningiomas, TERT expression—even without mutation—predicts early #recurrence, on par with a #WHO grade increase. https://t.co/CNGDmFN6Ta
#NeuroOncology #Biomarker #PrecisionMedicine
Excited to share our paper published in @TheLancetOncology showing #TERT expression (independent of mutation) is associated with earlier recurrence in #meningiomas. Thank you to my supervisors @GelarehZadeh @FarshadNassiri, coauthors, editors, reviewers
3
3
26
Appreciate & Proud to have @MayoClinic promote our discoveries #braintumor #meningioma research Thanks goes to the outstanding #neurosurgery #scientists #collaborators that make these findings to #transform care possible #team #science @ICOMeningioma @UHN Above all #Patients 🙏🏽
New research led by a Mayo Clinic neurosurgeon showed that meningiomas with TERT activity act more aggressively than their grade suggests. Learn more: https://t.co/wAxG5XHUr9
1
7
56